相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CXCL12 expression by healthy and malignant ovarian epithelial cells
Veronique Machelon et al.
BMC CANCER (2011)
Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential
Jan G. D'Haese et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2010)
Interactions between Chemokines REGULATION OF FRACTALKINE/CX3CL1 HOMEOSTASIS BY SDF/CXCL12 IN CORTICAL NEURONS
Anna Cook et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Role of CX3CR1/CX3CL1 axis in primary and secondary involvement of the nervous system by cancer
Federica Marchesi et al.
JOURNAL OF NEUROIMMUNOLOGY (2010)
Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis
K. Levanon et al.
ONCOGENE (2010)
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Gwendal Lazennec et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Ovarian Cancer Pathogenesis: A Model in Evolution
Alison M. Karst et al.
JOURNAL OF ONCOLOGY (2010)
An engineered CX3CR1 antagonist endowed with anti-inflammatory activity
Karim Dorgham et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Identification of glucocorticoid-induced leucine zipper as a key regulator of tumor cell proliferation in epithelial ovarian cancer
Nassima Redjimi et al.
MOLECULAR CANCER (2009)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
CX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: Potential role in prostate cancer bone tropism
Whitney L. Jamieson et al.
CANCER RESEARCH (2008)
The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma
Federica Marchesi et al.
CANCER RESEARCH (2008)
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Martin Koebel et al.
PLOS MEDICINE (2008)
Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ)
Weixi Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM
Steffen Runz et al.
GYNECOLOGIC ONCOLOGY (2007)
Progesterone increases csk homologous kinase in HMC-1560 human mast cells and reduces cell proliferation
Marie-Pierre Belot et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2007)
The clinical importance of Ki-67, p16, p14, and p57 expression in patients with advanced ovarian carcinoma
M. Haysam Khouja et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
Defective antitumor responses in CX3CR1-deficient mice
Yen-Rei A. Yu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Fractalkine-induced smooth muscle cell proliferation in pulmonary hypertension
F. Perros et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer
S. Vitale et al.
GUT (2007)
Perturbations of the AKT signaling pathway in human cancer
DA Altomare et al.
ONCOGENE (2005)
Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer
KK Zorn et al.
CLINICAL CANCER RESEARCH (2005)
Stromal cell-derived factor-1α (SDF-lα/CXCL12) stimulates ovarian cancer cell growth through the EGF receptor transactivation
C Porcile et al.
EXPERIMENTAL CELL RESEARCH (2005)
Ovarian cancer metastasis: Integrating insights from disparate model organisms
H Naora et al.
NATURE REVIEWS CANCER (2005)
Expression of fractalkine in the Fallopian tube and of CX3CR1 in sperm
Q Zhang et al.
HUMAN REPRODUCTION (2004)
G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells
N Gao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth
DA Altomare et al.
ONCOGENE (2004)
CX3CR1-fractalkine expression regulates cellular mechanisms involved in adhesion, migration, and survival of human prostate cancer cells
SA Shulby et al.
CANCER RESEARCH (2004)
Coexpression of fractalkine and its receptor in normal human endometrium and in endometrium from users of progestin-only contraception supports a role for fractalkine in leukocyte recruitment and endometrial remodeling
NJ Hannan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
GILZ, a new target for the transcription factor FoxO3, protects T lymphocytes from interleukin-2 withdrawal-induced apoptosis
ML Asselin-Labat et al.
BLOOD (2004)
Ovarian tumorigenesis - A proposed model based on morphological and molecular genetic analysis
IM Shih et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Chemoattraction, adhesion and activation of natural killer cells are involved in the antitumor immune response induced by fractalkine/CX3CL1
J Guo et al.
IMMUNOLOGY LETTERS (2003)
Fractalkine (CX3CL1) stimulated by nuclear factor κB (NF-κB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway
B Chandrasekar et al.
BIOCHEMICAL JOURNAL (2003)
Fractalkine transgene induces T-cell-dependent antitumor immunity through chemoattraction and activation of dendritic cells
J Guo et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Glucocorticoid-induced leucine zipper inhibits the raf-extracellular signal-regulated kinase pathway by binding to Raf-1
E Ayroldi et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Fractalkine-mediated signals regulate cell-survival and immune-modulatory responses in intestinal epithelial cells
S Brand et al.
GASTROENTEROLOGY (2002)
Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells
WP Zou et al.
NATURE MEDICINE (2001)
The transmembrane form of the CX3CL1 chemokine fractalkine is expressed predominantly by epithelial cells in vivo
AD Lucas et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
CX3C-chemokine, fractalkine-enhanced adhesion of THP-1 cells to endothelial cells through integrin-dependent and -independent mechanisms
S Goda et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
